Skip to main content
Have a personal or library account? Click to login
D-Amphetamine Toxicity in Freshly Isolated Rat Hepatocytes: A Possible Role of CYP3A Cover

D-Amphetamine Toxicity in Freshly Isolated Rat Hepatocytes: A Possible Role of CYP3A

Open Access
|Jul 2009

References

  1. Caldwell J. The metabolism of amphetamines and related stimulants in animals and man. In: Caldwell J, editor. Amphetamines and related stimulants: Chemical biological and sociological aspects. Boca Raton: CRC Press Inc.; 1980. p. 29-46.
  2. Bach MV, Coutts RT, Baker GB. Involvement of CYP2D6 in themetabolism of amphetamine, two N-alkylamphetamines and their 4-methoxylated derivatives.1999;29:719-32.
  3. Law MY, Slawson MH, Moody DE. Selective involvement of cytochrome P450 2D subfamily in4-hydroxylation of amphetamine in rat.2000;28:348-53.
  4. Carvalho F, Remião F, Amado F, Domingues P, Correia AJ, Bastos ML. D-Amphetamine interaction with glutathione in freshly isolated rat hepatocytes.1996;9:1031-6.
  5. Yanada H, Oguri K, Yoshimura H. Effects of several factors on urinary excretion of methamphetamine and its metabolites in rats.1986;16:137-41.
  6. Timbrell J. 2000. Factors affecting metabolism and disposition — Enzyme inhibition. In: Principles of Biochemical Toxicology. 3ed. New York (NY): Taylor and Francis; 2000. p. 164-5.
  7. Graham RJ, Benet LZ. Antiprogestin-mediated inactivation of cytochrome P 450 CYP 3A4.1998;56:150-7.
  8. Council of Europe. European Convention for the Protection of Vertebrate Animals used for Experimental and other Scientific Purposes. CETS No. 123, 1991 [displayed 30 May 2007] Available at
  9. Vitcheva V, Mitcheva M. Effect of nifedipine on behavioral and biochemical parameters in rats after multiple morphine administration.2004;26:631-4.
  10. Fau D, Berson A, Eugene D, Formently B, Fisch C, Pessayre D. Mechanism for the hepatotoxicity of the antiandrogen Nilutamide. Evidence suggesting that redox cycling of this nitroaromatic drug lead to oxidative stress in isolated hepatocytes.1992;263:69-77.
  11. Mitcheva M, Kondeva M, Vitcheva V, Nedialkov P, Kitanov G. Effect of benzophenones from Hypericum annulatum on carbon tetrachloride-induced toxicity in freshly isolated rat hepatocytes.2006;11:3-8.
  12. Ohyama K, Nakajiama M, Suzuki M, Shimada N, Yamazaki H, Yoki T. Inhibitory effects of amiodarone and its N-deethylated metabolite on human cytochrome P 450 activities: prediction ofdrug interactions.2000;49:244-53.
  13. Bergmeyer HU, editor. Methods of enzymatic analysis. Vol 1. New York (NY) / London: Verlag Chemie — Academic Press; 1974.
  14. Advokat C. Update on amphetamine neurotoxicity and its relevance to the treatment of ADHD.2007;11:8-16.
  15. Carvalho F, Remião F, Soares ME, Catarino R, Queiroz G, Bastos ML. D-Amphetamine-induced hepatotoxicity: possible contribution of catecholamines and hyperthermia to the effects studied in isolated hepatocytes.1997;71:429-36.
  16. Jones AJ, Simpson KJ. Review article: mechanisms and management of hepatotoxicity in ecstasy (MDMA) and amphetamine intoxications.1999;13:129-33.
  17. Maurer HH, Kraemer T, Springer D, Staack RF. Chemistry, pharmacology, toxicology, and hepatic metabolism of designer drugs of the amphetamine (ecstasy), piperazine, and pyrrolidinophenone types: a synopsis.2004;26:127-31.
  18. Antoniou T, Tseng AL. Interactions between recreational drugs and antiretroviral agents.2002;36:1598-613.
  19. Shulman A, Jagoda J, Laycock G, Kelly H. Calcium channel blocking drugs in the management of drug dependence, withdrawal and craving. A clinical pilot study with nifedipine and verapamil.1998;27(Suppl 1):S19-24.
  20. Kastelova A, Koleva M, Staneva-Stoytcheva D. Changes in rat liver monooxygenase activities after administration of atenolol, nifedipine and diltiazem alone and in combination.2000;22:627-31.
  21. Drocourt L, Pascussi JM, Assenat E, Fabre JM, Maurel P, Vilarem MJ. Calcium channel modulators of the dihydropyridine family are human pregnane X receptor activators and inducers of CYP 3A, CYP 2B and CYP 2C in human hepatocytes.2001;29:1325-31.
  22. Diehl KH, Hull R, Morton D, Pfizer R, Rabemampianina Y, Smith D, Vidal JM, van de Vorstenbosch C. A good practice guide to the administration of substances and removal of blood, including routs and volumes.2001;21:15-23.
  23. Coleman MD. Human Drug Metabolism. West Sussex: John Wiley and Sons; 2006.
  24. Ha HR, Bigler L, Binder M, Korlik P, Stieger B, Heese M, Altorfer HR, Follath F. Metabolism of amiodarone (part I): identification of a new hydroxylated metabolite of amiodarone.2001;29:152-8.
DOI: https://doi.org/10.2478/10004-1254-60-2009-1912 | Journal eISSN: 1848-6312 (formerly 0004-1254) | Journal ISSN: 0004-1254
Language: English
Page range: 139 - 145
Published on: Jul 6, 2009
Published by: Institute for Medical Research and Occupational Health
In partnership with: Paradigm Publishing Services

© 2009 Vessela Vitcheva, Magdalena Kondeva-Burdina, Mitka Mitcheva, published by Institute for Medical Research and Occupational Health
This work is licensed under the Creative Commons License.